The acquisition of Nexus Medical is being leveraged through existing NICU sales channels, exceeding initial integration expectations.Profitability in 2025 was significantly obscured by tariff impacts, prompting a comprehensive internal cost containment and pricing strategy to protect margins.Surgical pain performance was hindered by slower-than-anticipated hospital implementation of the NOPAIN Act reimbursement, despite Avanos holding several approved devices.The Pain Management portfolio saw double-digit g ...